Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 1, 2002, Pages 7-14

  Löscher, Wolfgang ^a   Potschka, Heidrun ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ACTIVE TRANSPORT; ADAPTATION; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; DRUG PENETRATION; DRUG RESISTANCE; DRUG TRANSPORT; DRUG UPTAKE; ENDOTHELIUM CELL; EPILEPSY; EPILEPTOGENESIS; GENE OVEREXPRESSION; LIPOPHILICITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; DRUG RESISTANCE; EPILEPSY; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 0036128985     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.1.7     Document Type: Review

References (59)

1. Drug resistance in epilepsy: The role of the blood-brain barrier
2. Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system
3. Blood-brain-cerebrospinal fluid barriers
4. The multidrug resistance protein family
5. A family of drug transporters: The multidrug resistance-associated proteins
6. Epilepsy
7. Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution
8. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes
9. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
10. Epilepsy and the blood-brain barrier
11. Drug delivery via the blood-brain barrier
12. Distribution of valproate across the interface between blood and cerebrospinal fluid
13. P-glycoprotein a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
14. Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain
15. Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro
16. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
17. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells
18. Interaction of drugs with P-glycoprotein in brain capillaries
19. ABC drug transporters: Hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
20. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat
21. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
22. The biology of the P-glycoproteins
23. From MDR to MXR new understanding of multidrug resistance systems, their properties and clinical significance
24. Basic mechanisms of seizure spread
25. GABA in plasma, CSF and brain of dogs during acute and chronic treatment with y-acetylenic GABA and valproic acid
26. Animal models of intractable epilepsy
27. Current status and future directions in the pharmacotherapy of epilepsy
28. Kinetics of penetration of common antiepileptics drugs into cerebrospinal fluid
29. Strategies in antiepileptic drug development: Is rational drug design superior to random screening and structural variation?
30. Saturable transport of gabapentin at the blood-brain barrier
31. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy
32. Carbamazepine is not a substrate for P-glycoprotein
33. Blood-brain barrier biology and methodology
34. P-Glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain
35. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain
36. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats
37. A comparison of extracellular levels of phenytoin in amygdala and hippocampus of kindled and non-kindled rats
38. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier
39. Clinical aspects and biological bases of drug-resistant epilepsies
40. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells
41. The multidrug transporters - Proteins of an ancient immune system
42. P-Glycoprotein, a gatekeeper in the blood-brain barrier
43. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
44. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
45. Modulators and substrates for P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
46. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: A comparison
47. Valproate: Absorption, distribution, and excretion
48. P-Glycoprotein-mediated antiepileptic drug transport: A role in refractory epilepsy?
49. Over-expression of P-glycoprotein in malformations of cortical development
50. Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy
51. Multidrug-resistance protein 1 in focal cortical dysplasia
52. Drug transport in the mammalian central nervous system: Multiple complex systems. A critical analysis and commentary
53. Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice
54. Multidrug resistance transporters and modulation
55. MDR1 gene expression in brain of patients with medically intractable epilepsy
56. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
57. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells
58. Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections